Cargando…
The Emerging Landscape of Natural Small-molecule Therapeutics for Huntington’s Disease
Huntington’s disease (HD) is a rare and fatal neurodegenerative disorder with no disease-modifying therapeutics. HD is characterized by extensive neuronal loss and is caused by the inherited expansion of the huntingtin (HTT) gene that encodes a toxic mutant HTT (mHTT) protein having expanded polyglu...
Autores principales: | Bhat, Shahnawaz Ali, Ahamad, Shakir, Dar, Nawab John, Siddique, Yasir Hassan, Nazir, Aamir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227909/ https://www.ncbi.nlm.nih.gov/pubmed/36797612 http://dx.doi.org/10.2174/1570159X21666230216104621 |
Ejemplares similares
-
Editorial: Investigating the molecular targets and therapeutic potential of Withania somnifera (Ashwagandha) in various pathophysiological conditions
por: Dar, Nawab John, et al.
Publicado: (2023) -
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Overview, Treatment, and a Case Study
por: Ponnala, Madhusudhan, et al.
Publicado: (2023) -
Therapeutic Potential and Pharmaceutical Development of Thymoquinone: A Multitargeted Molecule of Natural Origin
por: Goyal, Sameer N., et al.
Publicado: (2017) -
Editorial: Metal-complexed molecules of natural and synthetic origin: Pharmacological advances and therapeutic applications
por: Mohapatra, Ranjan K., et al.
Publicado: (2022) -
International Guidelines for the Treatment of Huntington's Disease
por: Bachoud-Lévi, Anne-Catherine, et al.
Publicado: (2019)